A group of international experts is challenging revised diagnostic criteria for Alzheimer’s disease (AD) as laid out by the ...

to lowering an individual’s risk of Alzheimer’s disease. This analysis was conducted by researchers at Case Western Reserve ...

After some time, early symptomatic Alzheimer's disease begins with a small amount of memory loss and confusion that can be ...

Alzheimer’s currently affects over 55 million people worldwide, with cases expected to triple by 2050. Advances in diagnostic methods that are faster, less invasive, and more affordable could enable ...

"We showed people with Alzheimer's disease have more gut inflammation," University of Wisconsin psychologist Barbara Bendlin ...

Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...

Popular Diabetes and Weight-Loss Drug May Reduce Risk of Alzheimer's Disease Oct. 24, 2024 — Researchers have found that semaglutide may lower the risk of Alzheimer's disease in people with type ...

Nearly 7 million Americans 65 and older are living with Alzheimer’s disease, which gradually destroys memory and thinking ...

The Alzheimer's disease drug Kisunla will face major reimbursement challenges in the U.K. after the cost-effectiveness ...

Semaglutide, the weight management drug sold as Ozempic and Wegovy, may reduce the risk of Alzheimer's disease by 40% to 70% ...

The National Institutes of Health reports that incidences of Alzheimer's disease and other dementia increased by roughly 148 ...

New treatments for Alzheimer disease don’t reverse cognitive symptoms, but they do significantly slow progression. Evidence suggests that earlier treatment is most effective.